During the past decade, service de rhumatologie - CHU de Limoges conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "service de rhumatologie - CHU de Limoges" are "Ankylosing Spondylitis" (1 trials), "Covid19" (1 trials), "Fibromyalgia" (1 trials), "Inflammatory Arthritis" (1 trials) and "Inflammatory Rheumatism" (1 trials). Many other conditions were trialed in "service de rhumatologie - CHU de Limoges" in a lesser frequency.

Most popular intervention types in "service de rhumatologie - CHU de Limoges" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dolasetron" (1 trials), "NSAIDs" (1 trials), "Placebo" (1 trials), "SePaRIC-Covid19 cohort" (1 trials) and "anti-TNF" (1 trials). Other intervention names were less common.

The vast majority of trials in "service de rhumatologie - CHU de Limoges" are 3 trials for "All" genders.

Currently, there are NaN active trials in "service de rhumatologie - CHU de Limoges". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in service de rhumatologie - CHU de Limoges, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in service de rhumatologie - CHU de Limoges, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".